Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Angiography | 83 | 2020 | 1431 | 6.360 |
Why?
|
Magnetic Resonance Imaging, Cine | 61 | 2024 | 1046 | 5.050 |
Why?
|
Echocardiography | 64 | 2024 | 4981 | 4.620 |
Why?
|
Magnetic Resonance Imaging | 164 | 2024 | 36286 | 3.450 |
Why?
|
Ventricular Function, Left | 49 | 2024 | 3880 | 3.350 |
Why?
|
Coronary Vessels | 63 | 2020 | 3112 | 3.320 |
Why?
|
Heart Atria | 35 | 2024 | 1346 | 3.160 |
Why?
|
Atrial Fibrillation | 50 | 2022 | 5209 | 2.660 |
Why?
|
Image Enhancement | 56 | 2021 | 2881 | 2.510 |
Why?
|
Cardiology | 23 | 2022 | 1723 | 2.400 |
Why?
|
Heart Ventricles | 37 | 2024 | 3812 | 2.350 |
Why?
|
Hypertrophy, Left Ventricular | 24 | 2019 | 854 | 2.280 |
Why?
|
Ventricular Dysfunction, Left | 23 | 2024 | 2128 | 2.280 |
Why?
|
Pulmonary Veins | 17 | 2016 | 745 | 2.170 |
Why?
|
Gadolinium | 27 | 2024 | 959 | 2.170 |
Why?
|
Atrial Appendage | 7 | 2016 | 292 | 2.160 |
Why?
|
Echocardiography, Transesophageal | 26 | 2022 | 1108 | 2.060 |
Why?
|
Image Interpretation, Computer-Assisted | 36 | 2022 | 3340 | 2.020 |
Why?
|
Cardiomyopathy, Hypertrophic | 30 | 2023 | 1311 | 1.890 |
Why?
|
Stroke Volume | 41 | 2024 | 5523 | 1.870 |
Why?
|
Contrast Media | 58 | 2024 | 5305 | 1.790 |
Why?
|
Imaging, Three-Dimensional | 47 | 2019 | 4046 | 1.770 |
Why?
|
Heart | 45 | 2023 | 4393 | 1.660 |
Why?
|
Aortic Valve Insufficiency | 6 | 2020 | 584 | 1.630 |
Why?
|
Respiratory-Gated Imaging Techniques | 10 | 2022 | 75 | 1.490 |
Why?
|
Aortic Diseases | 12 | 2022 | 734 | 1.480 |
Why?
|
Cicatrix | 16 | 2023 | 782 | 1.460 |
Why?
|
Electric Countershock | 14 | 2013 | 537 | 1.410 |
Why?
|
Gadolinium DTPA | 23 | 2017 | 823 | 1.390 |
Why?
|
Predictive Value of Tests | 65 | 2024 | 15286 | 1.370 |
Why?
|
Mitral Valve Insufficiency | 12 | 2022 | 1419 | 1.360 |
Why?
|
Echocardiography, Doppler | 10 | 2019 | 901 | 1.350 |
Why?
|
Editorial Policies | 6 | 2022 | 457 | 1.350 |
Why?
|
Heart Diseases | 24 | 2019 | 2809 | 1.330 |
Why?
|
Coronary Angiography | 37 | 2020 | 4563 | 1.320 |
Why?
|
Cardiovascular Diseases | 32 | 2022 | 15760 | 1.310 |
Why?
|
Myocardium | 36 | 2024 | 4700 | 1.300 |
Why?
|
Takotsubo Cardiomyopathy | 2 | 2020 | 124 | 1.250 |
Why?
|
Atrial Function, Left | 6 | 2018 | 186 | 1.250 |
Why?
|
Aorta, Thoracic | 15 | 2024 | 1095 | 1.200 |
Why?
|
Periodicals as Topic | 7 | 2021 | 1469 | 1.170 |
Why?
|
Papillary Muscles | 9 | 2024 | 192 | 1.150 |
Why?
|
Coronary Disease | 25 | 2022 | 5991 | 1.090 |
Why?
|
Aorta, Abdominal | 9 | 2013 | 622 | 1.070 |
Why?
|
Thromboembolism | 10 | 2014 | 1016 | 1.050 |
Why?
|
Accreditation | 3 | 2019 | 477 | 1.010 |
Why?
|
Ventricular Remodeling | 12 | 2020 | 1261 | 1.000 |
Why?
|
Artifacts | 25 | 2021 | 1898 | 1.000 |
Why?
|
Organometallic Compounds | 13 | 2019 | 662 | 0.990 |
Why?
|
Cardiomyopathy, Dilated | 9 | 2024 | 819 | 0.990 |
Why?
|
Tricuspid Valve Insufficiency | 4 | 2022 | 355 | 0.970 |
Why?
|
Aortic Valve Stenosis | 7 | 2017 | 2065 | 0.960 |
Why?
|
Meglumine | 8 | 2019 | 145 | 0.930 |
Why?
|
Catheter Ablation | 13 | 2018 | 2758 | 0.900 |
Why?
|
Coronary Artery Disease | 26 | 2022 | 6659 | 0.900 |
Why?
|
Humans | 410 | 2024 | 760613 | 0.890 |
Why?
|
Incidental Findings | 4 | 2014 | 698 | 0.850 |
Why?
|
Ventricular Function, Right | 6 | 2020 | 610 | 0.850 |
Why?
|
Image Processing, Computer-Assisted | 43 | 2017 | 8950 | 0.840 |
Why?
|
Reproducibility of Results | 63 | 2024 | 20080 | 0.820 |
Why?
|
Electrocardiography | 36 | 2023 | 6415 | 0.820 |
Why?
|
Sensitivity and Specificity | 52 | 2020 | 14661 | 0.790 |
Why?
|
Middle Aged | 201 | 2024 | 220359 | 0.790 |
Why?
|
Male | 266 | 2024 | 359718 | 0.790 |
Why?
|
Myocardial Contraction | 8 | 2019 | 1516 | 0.780 |
Why?
|
Female | 264 | 2024 | 391246 | 0.770 |
Why?
|
Aortic Valve | 7 | 2019 | 1996 | 0.770 |
Why?
|
Cardiomyopathies | 8 | 2024 | 1951 | 0.740 |
Why?
|
Warfarin | 11 | 2015 | 1518 | 0.740 |
Why?
|
Aged | 154 | 2024 | 169143 | 0.730 |
Why?
|
Biomedical Research | 4 | 2021 | 3426 | 0.730 |
Why?
|
Syncope | 2 | 2020 | 428 | 0.720 |
Why?
|
Mitral Valve Prolapse | 7 | 2020 | 215 | 0.720 |
Why?
|
Pulmonary Embolism | 8 | 2024 | 2543 | 0.710 |
Why?
|
Respiration | 21 | 2021 | 1654 | 0.710 |
Why?
|
Mitral Valve | 8 | 2017 | 1486 | 0.660 |
Why?
|
Ventricular Dysfunction, Right | 3 | 2022 | 615 | 0.660 |
Why?
|
Diaphragm | 5 | 2013 | 351 | 0.650 |
Why?
|
Coronary Vessel Anomalies | 6 | 2003 | 317 | 0.640 |
Why?
|
Aortography | 2 | 2019 | 419 | 0.630 |
Why?
|
Journal Impact Factor | 5 | 2021 | 156 | 0.620 |
Why?
|
Bundle-Branch Block | 2 | 2018 | 281 | 0.620 |
Why?
|
Pericardium | 7 | 2018 | 675 | 0.620 |
Why?
|
Adult | 174 | 2024 | 220007 | 0.620 |
Why?
|
Coronary Aneurysm | 6 | 2008 | 233 | 0.610 |
Why?
|
Defibrillators, Implantable | 9 | 2024 | 1499 | 0.600 |
Why?
|
Myocardial Infarction | 17 | 2022 | 11890 | 0.600 |
Why?
|
Cardiac Imaging Techniques | 2 | 2017 | 269 | 0.580 |
Why?
|
Algorithms | 27 | 2022 | 13982 | 0.580 |
Why?
|
Arteriosclerosis | 8 | 2004 | 1064 | 0.560 |
Why?
|
Thrombosis | 12 | 2016 | 3051 | 0.560 |
Why?
|
Coronary Thrombosis | 6 | 2013 | 486 | 0.560 |
Why?
|
Outpatients | 3 | 2015 | 1607 | 0.550 |
Why?
|
Cardiac-Gated Imaging Techniques | 8 | 2014 | 140 | 0.550 |
Why?
|
Clinical Competence | 6 | 2021 | 4783 | 0.540 |
Why?
|
Anticoagulants | 12 | 2015 | 4897 | 0.530 |
Why?
|
Guideline Adherence | 5 | 2015 | 2283 | 0.530 |
Why?
|
Coronary Circulation | 9 | 2014 | 1577 | 0.530 |
Why?
|
Reference Values | 17 | 2024 | 4925 | 0.530 |
Why?
|
Phantoms, Imaging | 20 | 2021 | 2512 | 0.520 |
Why?
|
Fibrosis | 16 | 2024 | 2042 | 0.520 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3085 | 0.520 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3205 | 0.510 |
Why?
|
Respiratory Mechanics | 6 | 2014 | 699 | 0.500 |
Why?
|
Blood Flow Velocity | 7 | 2021 | 1377 | 0.490 |
Why?
|
Aging | 6 | 2014 | 8652 | 0.490 |
Why?
|
Prognosis | 32 | 2024 | 29661 | 0.490 |
Why?
|
Heart Murmurs | 1 | 2015 | 94 | 0.490 |
Why?
|
Observer Variation | 10 | 2019 | 2601 | 0.490 |
Why?
|
Systole | 6 | 2017 | 947 | 0.480 |
Why?
|
Coronary Stenosis | 7 | 2020 | 820 | 0.480 |
Why?
|
Heart Valve Diseases | 4 | 2017 | 1047 | 0.470 |
Why?
|
Atrial Flutter | 3 | 2014 | 258 | 0.470 |
Why?
|
Aged, 80 and over | 49 | 2024 | 58980 | 0.460 |
Why?
|
Pacemaker, Artificial | 2 | 2017 | 815 | 0.460 |
Why?
|
Pulmonary Edema | 1 | 2017 | 409 | 0.460 |
Why?
|
Pattern Recognition, Automated | 4 | 2014 | 994 | 0.460 |
Why?
|
Patient Care | 1 | 2019 | 624 | 0.450 |
Why?
|
Heart Failure | 15 | 2024 | 11848 | 0.440 |
Why?
|
Nuclear Medicine | 2 | 2014 | 236 | 0.440 |
Why?
|
Heart Valves | 1 | 2015 | 285 | 0.430 |
Why?
|
Body Size | 2 | 2014 | 462 | 0.430 |
Why?
|
Myocardial Stunning | 3 | 2014 | 66 | 0.430 |
Why?
|
Tomography, X-Ray Computed | 22 | 2024 | 20509 | 0.430 |
Why?
|
Myocarditis | 1 | 2020 | 766 | 0.420 |
Why?
|
Stroke | 10 | 2022 | 9952 | 0.420 |
Why?
|
Internship and Residency | 3 | 2022 | 5870 | 0.410 |
Why?
|
Echo-Planar Imaging | 9 | 2002 | 657 | 0.410 |
Why?
|
Peer Review, Research | 3 | 2021 | 340 | 0.400 |
Why?
|
Heart Failure, Diastolic | 1 | 2012 | 76 | 0.400 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1266 | 0.390 |
Why?
|
Atherosclerosis | 7 | 2014 | 3518 | 0.380 |
Why?
|
Cardiac Volume | 5 | 2012 | 199 | 0.380 |
Why?
|
Radiography, Thoracic | 2 | 2017 | 1296 | 0.380 |
Why?
|
Echocardiography, Three-Dimensional | 8 | 2013 | 613 | 0.380 |
Why?
|
Bariatric Surgery | 2 | 2013 | 1005 | 0.370 |
Why?
|
Pleural Effusion | 1 | 2014 | 343 | 0.370 |
Why?
|
Exercise Test | 7 | 2024 | 2128 | 0.370 |
Why?
|
Plaque, Atherosclerotic | 6 | 2022 | 1518 | 0.360 |
Why?
|
Intra-Abdominal Fat | 2 | 2013 | 607 | 0.360 |
Why?
|
Pandemics | 5 | 2022 | 8623 | 0.360 |
Why?
|
Retrospective Studies | 43 | 2024 | 80345 | 0.360 |
Why?
|
General Practice | 1 | 2011 | 98 | 0.350 |
Why?
|
American Heart Association | 7 | 2017 | 1081 | 0.350 |
Why?
|
Diastole | 6 | 2022 | 788 | 0.350 |
Why?
|
Subcutaneous Fat | 1 | 2013 | 393 | 0.340 |
Why?
|
Prospective Studies | 48 | 2024 | 54306 | 0.340 |
Why?
|
Weight Loss | 2 | 2013 | 2684 | 0.340 |
Why?
|
Risk Factors | 51 | 2023 | 74333 | 0.330 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1822 | 0.320 |
Why?
|
Ambulatory Care Facilities | 1 | 2015 | 926 | 0.320 |
Why?
|
Fibrinolytic Agents | 3 | 2012 | 2167 | 0.320 |
Why?
|
Acrylic Resins | 1 | 2009 | 135 | 0.320 |
Why?
|
Perception | 1 | 2015 | 1195 | 0.310 |
Why?
|
Arrhythmias, Cardiac | 6 | 2024 | 2255 | 0.310 |
Why?
|
Quality Improvement | 3 | 2019 | 3835 | 0.310 |
Why?
|
Liver Diseases | 2 | 2014 | 1302 | 0.310 |
Why?
|
Ergocalciferols | 4 | 2012 | 110 | 0.300 |
Why?
|
Myocardial Perfusion Imaging | 4 | 2021 | 571 | 0.300 |
Why?
|
Cardiovascular System | 6 | 2020 | 850 | 0.300 |
Why?
|
Death, Sudden, Cardiac | 6 | 2023 | 1572 | 0.300 |
Why?
|
Time Factors | 38 | 2024 | 40139 | 0.300 |
Why?
|
Coronary Artery Bypass | 8 | 2007 | 2272 | 0.300 |
Why?
|
Organ Size | 9 | 2024 | 2254 | 0.290 |
Why?
|
Esophagus | 3 | 2010 | 1023 | 0.290 |
Why?
|
Body Fat Distribution | 1 | 2009 | 243 | 0.290 |
Why?
|
Gelatin | 1 | 2009 | 221 | 0.290 |
Why?
|
Veins | 2 | 2010 | 765 | 0.290 |
Why?
|
Pentetic Acid | 4 | 2004 | 209 | 0.280 |
Why?
|
Doxorubicin | 3 | 2024 | 2208 | 0.280 |
Why?
|
Societies, Medical | 9 | 2020 | 3905 | 0.280 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2007 | 106 | 0.280 |
Why?
|
Ultrasonography | 6 | 2021 | 5961 | 0.280 |
Why?
|
Premedication | 2 | 2006 | 253 | 0.280 |
Why?
|
Lung Diseases | 1 | 2017 | 1915 | 0.280 |
Why?
|
Hypothyroidism | 1 | 2011 | 665 | 0.270 |
Why?
|
Signal Processing, Computer-Assisted | 9 | 2016 | 1489 | 0.270 |
Why?
|
Stilbenes | 3 | 2012 | 155 | 0.270 |
Why?
|
Follow-Up Studies | 26 | 2018 | 39262 | 0.270 |
Why?
|
Hyperventilation | 2 | 2013 | 79 | 0.270 |
Why?
|
Antibiotic Prophylaxis | 2 | 2002 | 643 | 0.260 |
Why?
|
Hypertension | 8 | 2019 | 8595 | 0.260 |
Why?
|
Diagnostic Imaging | 3 | 2017 | 3527 | 0.260 |
Why?
|
Health Status Indicators | 2 | 2010 | 968 | 0.260 |
Why?
|
Cheyne-Stokes Respiration | 1 | 2005 | 38 | 0.260 |
Why?
|
Endomyocardial Fibrosis | 2 | 2020 | 41 | 0.260 |
Why?
|
Body Surface Area | 2 | 2024 | 197 | 0.250 |
Why?
|
Leadership | 3 | 2021 | 1371 | 0.250 |
Why?
|
Inflammation Mediators | 2 | 2013 | 1881 | 0.250 |
Why?
|
Heart Conduction System | 3 | 2019 | 1015 | 0.250 |
Why?
|
Sex Factors | 10 | 2018 | 10546 | 0.250 |
Why?
|
Case-Control Studies | 21 | 2019 | 22052 | 0.250 |
Why?
|
Aorta | 6 | 2013 | 2039 | 0.240 |
Why?
|
Obesity | 8 | 2016 | 12919 | 0.240 |
Why?
|
Motion | 12 | 2014 | 779 | 0.240 |
Why?
|
Registries | 3 | 2019 | 8458 | 0.240 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 2 | 2007 | 537 | 0.240 |
Why?
|
Heart Rate | 9 | 2019 | 4180 | 0.240 |
Why?
|
Severity of Illness Index | 15 | 2019 | 15840 | 0.240 |
Why?
|
Dobutamine | 1 | 2004 | 116 | 0.230 |
Why?
|
Myocardial Ischemia | 6 | 2013 | 2164 | 0.230 |
Why?
|
Acute Disease | 6 | 2023 | 7268 | 0.220 |
Why?
|
Tachycardia, Ventricular | 4 | 2017 | 1303 | 0.220 |
Why?
|
Benzocaine | 1 | 2003 | 14 | 0.220 |
Why?
|
Treatment Outcome | 24 | 2022 | 64981 | 0.220 |
Why?
|
Heart Valve Prosthesis | 3 | 2013 | 1495 | 0.220 |
Why?
|
Swine, Miniature | 2 | 2024 | 959 | 0.210 |
Why?
|
Quality of Health Care | 2 | 2015 | 4360 | 0.210 |
Why?
|
Pulmonary Artery | 4 | 2020 | 1921 | 0.210 |
Why?
|
Risk Assessment | 23 | 2024 | 24102 | 0.210 |
Why?
|
Postoperative Period | 4 | 2018 | 1818 | 0.210 |
Why?
|
Methemoglobinemia | 1 | 2003 | 43 | 0.210 |
Why?
|
Radiation Injuries | 3 | 2002 | 1183 | 0.210 |
Why?
|
Primary Prevention | 3 | 2024 | 1207 | 0.210 |
Why?
|
Surgery, Computer-Assisted | 2 | 2008 | 1007 | 0.210 |
Why?
|
Tricuspid Valve | 3 | 2020 | 409 | 0.210 |
Why?
|
Graft Occlusion, Vascular | 2 | 2003 | 560 | 0.210 |
Why?
|
Academic Medical Centers | 3 | 2019 | 2754 | 0.200 |
Why?
|
Postoperative Care | 1 | 2009 | 1479 | 0.200 |
Why?
|
Radiographic Image Enhancement | 2 | 2004 | 875 | 0.200 |
Why?
|
Adipose Tissue | 5 | 2018 | 3300 | 0.200 |
Why?
|
Data Compression | 2 | 2014 | 69 | 0.200 |
Why?
|
Radiology | 2 | 2014 | 2102 | 0.200 |
Why?
|
Echocardiography, Stress | 1 | 2003 | 134 | 0.200 |
Why?
|
Evidence-Based Medicine | 3 | 2012 | 3696 | 0.200 |
Why?
|
Amyloidosis | 1 | 2008 | 817 | 0.200 |
Why?
|
Heart Septal Defects, Atrial | 2 | 2022 | 461 | 0.190 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2024 | 3765 | 0.190 |
Why?
|
Inhalation | 1 | 2002 | 143 | 0.190 |
Why?
|
Prevalence | 16 | 2022 | 15686 | 0.190 |
Why?
|
Advisory Committees | 4 | 2019 | 788 | 0.190 |
Why?
|
Thoracic Surgery | 2 | 2017 | 725 | 0.190 |
Why?
|
Echocardiography, Doppler, Color | 3 | 2013 | 354 | 0.190 |
Why?
|
Tricuspid Valve Prolapse | 1 | 2020 | 6 | 0.190 |
Why?
|
Cardiotonic Agents | 1 | 2004 | 546 | 0.190 |
Why?
|
Injections, Intravenous | 3 | 2012 | 1385 | 0.190 |
Why?
|
Patient Compliance | 2 | 2002 | 2688 | 0.180 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2006 | 465 | 0.180 |
Why?
|
Subtraction Technique | 2 | 2014 | 510 | 0.180 |
Why?
|
Adiposity | 2 | 2018 | 1858 | 0.180 |
Why?
|
Information Storage and Retrieval | 1 | 2006 | 822 | 0.180 |
Why?
|
Cohort Studies | 21 | 2022 | 41337 | 0.180 |
Why?
|
Ambulatory Care | 1 | 2011 | 2782 | 0.180 |
Why?
|
Heparin, Low-Molecular-Weight | 3 | 2008 | 345 | 0.170 |
Why?
|
Cardiac Output, Low | 2 | 2015 | 192 | 0.170 |
Why?
|
Allied Health Personnel | 1 | 2021 | 156 | 0.170 |
Why?
|
Prone Position | 1 | 2001 | 196 | 0.170 |
Why?
|
Dextrocardia | 1 | 1999 | 37 | 0.170 |
Why?
|
Hypertension, Pulmonary | 1 | 2010 | 1570 | 0.170 |
Why?
|
Ventricular Outflow Obstruction | 6 | 2014 | 265 | 0.170 |
Why?
|
Angioplasty, Balloon, Coronary | 5 | 2010 | 1880 | 0.170 |
Why?
|
Situs Inversus | 1 | 1999 | 63 | 0.170 |
Why?
|
Postoperative Complications | 5 | 2017 | 15679 | 0.170 |
Why?
|
Age Factors | 11 | 2016 | 18413 | 0.170 |
Why?
|
Massachusetts | 10 | 2016 | 8803 | 0.160 |
Why?
|
Feasibility Studies | 12 | 2022 | 5201 | 0.160 |
Why?
|
Stents | 8 | 2007 | 3303 | 0.160 |
Why?
|
Swine | 10 | 2024 | 5899 | 0.160 |
Why?
|
Embolization, Therapeutic | 1 | 2009 | 1412 | 0.160 |
Why?
|
Embolism | 1 | 2022 | 408 | 0.160 |
Why?
|
Practice Guidelines as Topic | 7 | 2020 | 7475 | 0.160 |
Why?
|
Heparin | 6 | 2006 | 1652 | 0.160 |
Why?
|
Kidney Diseases | 3 | 2017 | 2093 | 0.160 |
Why?
|
Bone Density Conservation Agents | 3 | 2012 | 796 | 0.160 |
Why?
|
Boston | 4 | 2019 | 9278 | 0.150 |
Why?
|
Animals | 35 | 2024 | 167960 | 0.150 |
Why?
|
Analysis of Variance | 8 | 2014 | 6238 | 0.150 |
Why?
|
Kaplan-Meier Estimate | 7 | 2016 | 6544 | 0.150 |
Why?
|
Extracellular Matrix | 2 | 2024 | 1726 | 0.150 |
Why?
|
Endocarditis | 1 | 2002 | 351 | 0.150 |
Why?
|
Cross-Sectional Studies | 11 | 2022 | 25941 | 0.150 |
Why?
|
Troponin T | 2 | 2021 | 774 | 0.150 |
Why?
|
Bibliometrics | 2 | 2018 | 351 | 0.150 |
Why?
|
Linear Models | 9 | 2016 | 5877 | 0.150 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 1997 | 144 | 0.150 |
Why?
|
Heart Neoplasms | 2 | 2009 | 360 | 0.140 |
Why?
|
Decision Trees | 1 | 1999 | 506 | 0.140 |
Why?
|
Workers' Compensation | 1 | 2017 | 150 | 0.140 |
Why?
|
International Normalized Ratio | 3 | 2012 | 387 | 0.140 |
Why?
|
United States | 27 | 2022 | 72448 | 0.140 |
Why?
|
Cardiomyopathy, Hypertrophic, Familial | 1 | 2017 | 63 | 0.140 |
Why?
|
Cardiac Surgical Procedures | 2 | 2016 | 3620 | 0.140 |
Why?
|
Vasodilator Agents | 2 | 2012 | 978 | 0.140 |
Why?
|
Cardiac Myosins | 1 | 2017 | 127 | 0.140 |
Why?
|
Sus scrofa | 5 | 2019 | 433 | 0.130 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2019 | 546 | 0.130 |
Why?
|
Pulmonary Ventilation | 1 | 1998 | 371 | 0.130 |
Why?
|
Vitamin K | 3 | 2012 | 321 | 0.130 |
Why?
|
Single-Blind Method | 3 | 2014 | 1578 | 0.130 |
Why?
|
Leukoaraiosis | 1 | 2017 | 116 | 0.130 |
Why?
|
Endocarditis, Bacterial | 1 | 2000 | 445 | 0.130 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 2 | 2009 | 435 | 0.130 |
Why?
|
Tachycardia, Paroxysmal | 1 | 2015 | 30 | 0.130 |
Why?
|
Pilot Projects | 9 | 2021 | 8556 | 0.130 |
Why?
|
Anesthetics, Local | 1 | 2003 | 1001 | 0.130 |
Why?
|
Thorax | 3 | 2009 | 553 | 0.130 |
Why?
|
Coronary Care Units | 1 | 2017 | 235 | 0.130 |
Why?
|
Angina Pectoris | 1 | 2019 | 969 | 0.120 |
Why?
|
Myosin Heavy Chains | 1 | 2017 | 402 | 0.120 |
Why?
|
Albuminuria | 2 | 2017 | 659 | 0.120 |
Why?
|
Statistics, Nonparametric | 4 | 2012 | 2852 | 0.120 |
Why?
|
Body Surface Potential Mapping | 2 | 2014 | 228 | 0.120 |
Why?
|
Oxygen Inhalation Therapy | 1 | 1998 | 404 | 0.120 |
Why?
|
Heart Rupture, Post-Infarction | 1 | 1995 | 48 | 0.120 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 1 | 2016 | 162 | 0.120 |
Why?
|
Cause of Death | 2 | 2020 | 3725 | 0.120 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2020 | 577 | 0.120 |
Why?
|
Phenotype | 10 | 2017 | 16548 | 0.120 |
Why?
|
Ventricular Septum | 1 | 2015 | 76 | 0.120 |
Why?
|
Sarcoidosis | 1 | 2020 | 520 | 0.120 |
Why?
|
Blood | 1 | 2017 | 586 | 0.120 |
Why?
|
Proportional Hazards Models | 5 | 2015 | 12531 | 0.120 |
Why?
|
Cardiac Output | 3 | 2012 | 838 | 0.120 |
Why?
|
Medicare | 4 | 2022 | 6785 | 0.120 |
Why?
|
Awards and Prizes | 1 | 2018 | 359 | 0.120 |
Why?
|
Magnetics | 3 | 2011 | 600 | 0.120 |
Why?
|
Recurrence | 7 | 2018 | 8483 | 0.120 |
Why?
|
Anatomy, Cross-Sectional | 2 | 2006 | 141 | 0.110 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2022 | 936 | 0.110 |
Why?
|
Phlebography | 1 | 2015 | 325 | 0.110 |
Why?
|
Diagnosis, Differential | 8 | 2019 | 12968 | 0.110 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2017 | 385 | 0.110 |
Why?
|
Cerebrovascular Disorders | 2 | 1998 | 1501 | 0.110 |
Why?
|
Chi-Square Distribution | 4 | 2016 | 3465 | 0.110 |
Why?
|
Disease Progression | 7 | 2017 | 13505 | 0.110 |
Why?
|
Fibrin | 3 | 2005 | 505 | 0.110 |
Why?
|
Exercise | 2 | 2024 | 5787 | 0.110 |
Why?
|
Syndrome | 1 | 2019 | 3280 | 0.110 |
Why?
|
Ventricular Function | 2 | 2013 | 408 | 0.110 |
Why?
|
Multivariate Analysis | 8 | 2016 | 12159 | 0.110 |
Why?
|
Disease Models, Animal | 7 | 2024 | 18137 | 0.110 |
Why?
|
Artificial Intelligence | 2 | 2024 | 2557 | 0.110 |
Why?
|
Body Mass Index | 6 | 2013 | 12914 | 0.110 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2013 | 173 | 0.110 |
Why?
|
Physicians, Women | 1 | 2018 | 495 | 0.100 |
Why?
|
Brain | 5 | 2017 | 26951 | 0.100 |
Why?
|
Radiation Dosage | 4 | 2013 | 1957 | 0.100 |
Why?
|
Inpatients | 2 | 2016 | 2580 | 0.100 |
Why?
|
Conflict of Interest | 1 | 2017 | 549 | 0.100 |
Why?
|
Respiratory Physiological Phenomena | 2 | 2006 | 188 | 0.100 |
Why?
|
Body Water | 1 | 2013 | 341 | 0.100 |
Why?
|
User-Computer Interface | 3 | 2006 | 1403 | 0.100 |
Why?
|
Databases, Factual | 3 | 2018 | 8022 | 0.100 |
Why?
|
Chronic Disease | 3 | 2019 | 9288 | 0.100 |
Why?
|
Receptors, Calcitriol | 2 | 2011 | 359 | 0.100 |
Why?
|
Action Potentials | 1 | 2019 | 1816 | 0.100 |
Why?
|
Wavelet Analysis | 1 | 2011 | 55 | 0.100 |
Why?
|
Comorbidity | 4 | 2014 | 10553 | 0.100 |
Why?
|
Heart Septal Defects | 1 | 1992 | 191 | 0.090 |
Why?
|
Personnel, Hospital | 1 | 2013 | 285 | 0.090 |
Why?
|
Young Adult | 17 | 2019 | 58748 | 0.090 |
Why?
|
Biometry | 1 | 2014 | 559 | 0.090 |
Why?
|
Angiography | 4 | 2020 | 1605 | 0.090 |
Why?
|
Diltiazem | 1 | 1991 | 131 | 0.090 |
Why?
|
Equipment Design | 5 | 2014 | 3520 | 0.090 |
Why?
|
Cholelithiasis | 1 | 2012 | 408 | 0.090 |
Why?
|
Isosorbide Dinitrate | 1 | 2010 | 37 | 0.090 |
Why?
|
Diabetic Nephropathies | 2 | 2008 | 988 | 0.090 |
Why?
|
Adolescent | 20 | 2019 | 87809 | 0.090 |
Why?
|
Foundations | 1 | 2010 | 97 | 0.090 |
Why?
|
Utilization Review | 1 | 2011 | 383 | 0.090 |
Why?
|
Administration, Oral | 4 | 2012 | 4035 | 0.090 |
Why?
|
Incidence | 7 | 2022 | 21391 | 0.090 |
Why?
|
Mitral Valve Stenosis | 1 | 1992 | 348 | 0.080 |
Why?
|
Blood Pressure | 7 | 2012 | 8525 | 0.080 |
Why?
|
Ventricular Dysfunction | 1 | 2010 | 145 | 0.080 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2015 | 553 | 0.080 |
Why?
|
Anthropometry | 1 | 2014 | 1348 | 0.080 |
Why?
|
Vascular System Injuries | 1 | 2013 | 247 | 0.080 |
Why?
|
Septal Occluder Device | 1 | 2010 | 126 | 0.080 |
Why?
|
Calcinosis | 4 | 2011 | 1476 | 0.080 |
Why?
|
Bioprosthesis | 1 | 2013 | 600 | 0.080 |
Why?
|
Recovery of Function | 1 | 2019 | 2985 | 0.080 |
Why?
|
Vena Cava, Superior | 1 | 2009 | 197 | 0.080 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2019 | 1582 | 0.080 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 3 | 2019 | 1067 | 0.080 |
Why?
|
Breast | 1 | 1997 | 1963 | 0.080 |
Why?
|
Computer Systems | 3 | 2013 | 470 | 0.080 |
Why?
|
Rheology | 1 | 2009 | 348 | 0.080 |
Why?
|
Survival Rate | 5 | 2016 | 12810 | 0.080 |
Why?
|
Radiography | 4 | 2024 | 6965 | 0.080 |
Why?
|
Hernia, Hiatal | 1 | 2009 | 90 | 0.080 |
Why?
|
Fumarates | 1 | 2009 | 131 | 0.080 |
Why?
|
Testosterone | 1 | 2019 | 2470 | 0.080 |
Why?
|
Cardiovascular Physiological Phenomena | 2 | 2006 | 239 | 0.070 |
Why?
|
Myocytes, Cardiac | 4 | 2004 | 1657 | 0.070 |
Why?
|
Longitudinal Studies | 7 | 2022 | 14494 | 0.070 |
Why?
|
Glycemic Index | 1 | 2010 | 396 | 0.070 |
Why?
|
Foramen Ovale, Patent | 1 | 2010 | 214 | 0.070 |
Why?
|
Anesthesiology | 1 | 2017 | 1116 | 0.070 |
Why?
|
Valine | 1 | 2009 | 409 | 0.070 |
Why?
|
Fourier Analysis | 2 | 1999 | 439 | 0.070 |
Why?
|
Internet | 2 | 2020 | 3078 | 0.070 |
Why?
|
Losartan | 1 | 2009 | 265 | 0.070 |
Why?
|
Dyspnea | 2 | 2013 | 1353 | 0.070 |
Why?
|
Electrophysiologic Techniques, Cardiac | 2 | 2020 | 504 | 0.070 |
Why?
|
Angioplasty, Balloon | 1 | 1991 | 597 | 0.070 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2020 | 1860 | 0.070 |
Why?
|
Adenosine | 1 | 2012 | 834 | 0.070 |
Why?
|
Hemangioma | 1 | 2012 | 728 | 0.070 |
Why?
|
Injections, Subcutaneous | 1 | 2008 | 680 | 0.070 |
Why?
|
Tomography | 1 | 2009 | 411 | 0.070 |
Why?
|
Cysts | 1 | 2012 | 683 | 0.070 |
Why?
|
Supine Position | 2 | 2019 | 205 | 0.070 |
Why?
|
Area Under Curve | 2 | 2016 | 1635 | 0.070 |
Why?
|
Morbidity | 1 | 2012 | 1765 | 0.070 |
Why?
|
Catheterization | 1 | 1992 | 1432 | 0.070 |
Why?
|
Patient Readmission | 1 | 2020 | 3322 | 0.070 |
Why?
|
Kidney Failure, Chronic | 2 | 2011 | 2470 | 0.070 |
Why?
|
Science | 1 | 2009 | 239 | 0.070 |
Why?
|
Amides | 1 | 2009 | 448 | 0.070 |
Why?
|
Sex Distribution | 3 | 2013 | 2294 | 0.070 |
Why?
|
Water | 1 | 2012 | 1407 | 0.070 |
Why?
|
Carotid Artery, Common | 1 | 2006 | 177 | 0.070 |
Why?
|
Medical Staff Privileges | 1 | 2005 | 15 | 0.060 |
Why?
|
Tea | 1 | 2007 | 284 | 0.060 |
Why?
|
China | 1 | 2012 | 2339 | 0.060 |
Why?
|
Tachycardia | 1 | 2008 | 603 | 0.060 |
Why?
|
Age Distribution | 3 | 2013 | 2893 | 0.060 |
Why?
|
Cardiomegaly | 2 | 2003 | 593 | 0.060 |
Why?
|
Blood Vessel Prosthesis Implantation | 3 | 2005 | 1425 | 0.060 |
Why?
|
Medical Records Systems, Computerized | 1 | 2011 | 1191 | 0.060 |
Why?
|
Child | 12 | 2019 | 79799 | 0.060 |
Why?
|
Connexin 43 | 2 | 2003 | 200 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2010 | 2932 | 0.060 |
Why?
|
Muscles | 1 | 2009 | 1581 | 0.060 |
Why?
|
Athletes | 1 | 2012 | 1125 | 0.060 |
Why?
|
Elasticity | 2 | 2005 | 652 | 0.060 |
Why?
|
Heart Block | 1 | 2006 | 392 | 0.060 |
Why?
|
Clinical Trials as Topic | 4 | 2005 | 8055 | 0.060 |
Why?
|
Genetic Loci | 1 | 2014 | 2618 | 0.060 |
Why?
|
Tooth Extraction | 1 | 2006 | 229 | 0.060 |
Why?
|
Education, Medical, Graduate | 2 | 2008 | 2363 | 0.060 |
Why?
|
Neuregulin-1 | 1 | 2005 | 135 | 0.060 |
Why?
|
Aspirin | 3 | 2012 | 3364 | 0.060 |
Why?
|
Antioxidants | 1 | 2012 | 1667 | 0.060 |
Why?
|
Breast Neoplasms | 3 | 2002 | 21029 | 0.060 |
Why?
|
Wrestling | 1 | 2003 | 19 | 0.060 |
Why?
|
Glomerular Filtration Rate | 4 | 2017 | 2180 | 0.060 |
Why?
|
Diabetic Angiopathies | 1 | 2009 | 822 | 0.060 |
Why?
|
Sex Characteristics | 1 | 2014 | 2629 | 0.060 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 2003 | 60 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2017 | 4938 | 0.060 |
Why?
|
Movement | 3 | 2015 | 1474 | 0.060 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2012 | 1716 | 0.060 |
Why?
|
Renal Artery | 2 | 2002 | 370 | 0.060 |
Why?
|
Vitamins | 1 | 2012 | 1634 | 0.050 |
Why?
|
Models, Animal | 3 | 2005 | 2117 | 0.050 |
Why?
|
Hemodynamics | 5 | 2005 | 4173 | 0.050 |
Why?
|
Tetrazoles | 1 | 2009 | 905 | 0.050 |
Why?
|
Biopsy | 2 | 2024 | 6771 | 0.050 |
Why?
|
Thrombolytic Therapy | 2 | 2009 | 2108 | 0.050 |
Why?
|
Neovascularization, Physiologic | 1 | 2010 | 1336 | 0.050 |
Why?
|
Double-Blind Method | 6 | 2016 | 12427 | 0.050 |
Why?
|
Europe | 3 | 2017 | 3441 | 0.050 |
Why?
|
Acute Coronary Syndrome | 1 | 2016 | 2365 | 0.050 |
Why?
|
Safety | 1 | 2007 | 1148 | 0.050 |
Why?
|
ROC Curve | 2 | 2016 | 3568 | 0.050 |
Why?
|
Peptide Hormones | 1 | 2004 | 132 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2008 | 10343 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2020 | 12289 | 0.050 |
Why?
|
Homeodomain Proteins | 2 | 2003 | 2414 | 0.050 |
Why?
|
Treatment Failure | 1 | 2009 | 2647 | 0.050 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2008 | 3454 | 0.050 |
Why?
|
Radionuclide Imaging | 3 | 2013 | 1975 | 0.050 |
Why?
|
Heart Transplantation | 1 | 1996 | 3224 | 0.050 |
Why?
|
Peptides | 2 | 2005 | 4354 | 0.050 |
Why?
|
Abdomen | 2 | 1999 | 1130 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2012 | 1379 | 0.050 |
Why?
|
Xenopus Proteins | 2 | 2003 | 435 | 0.050 |
Why?
|
Oxygen | 1 | 2013 | 4193 | 0.050 |
Why?
|
Kidney | 1 | 2017 | 7064 | 0.050 |
Why?
|
Calcium-Transporting ATPases | 1 | 2001 | 122 | 0.050 |
Why?
|
Renal Artery Obstruction | 1 | 2002 | 224 | 0.050 |
Why?
|
Alzheimer Disease | 2 | 2015 | 8561 | 0.050 |
Why?
|
Mass Screening | 2 | 2012 | 5422 | 0.050 |
Why?
|
California | 1 | 2005 | 1416 | 0.050 |
Why?
|
Sinoatrial Node | 1 | 2001 | 99 | 0.050 |
Why?
|
Principal Component Analysis | 1 | 2024 | 939 | 0.050 |
Why?
|
Hospitals | 1 | 2014 | 3928 | 0.050 |
Why?
|
Fibrinogen | 1 | 2004 | 887 | 0.050 |
Why?
|
Bayes Theorem | 2 | 2024 | 2326 | 0.050 |
Why?
|
Fellowships and Scholarships | 2 | 2020 | 1116 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3865 | 0.050 |
Why?
|
Atrioventricular Node | 1 | 2001 | 180 | 0.050 |
Why?
|
Tunica Media | 1 | 2000 | 112 | 0.040 |
Why?
|
Nephrectomy | 1 | 2006 | 1016 | 0.040 |
Why?
|
Dementia | 1 | 2015 | 2650 | 0.040 |
Why?
|
Equipment Failure Analysis | 2 | 2014 | 848 | 0.040 |
Why?
|
Sarcomeres | 1 | 2003 | 367 | 0.040 |
Why?
|
Procainamide | 1 | 1999 | 56 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2024 | 675 | 0.040 |
Why?
|
Myocardial Revascularization | 1 | 2004 | 841 | 0.040 |
Why?
|
Pharynx | 1 | 2003 | 432 | 0.040 |
Why?
|
Colonoscopy | 2 | 2006 | 1387 | 0.040 |
Why?
|
Models, Theoretical | 3 | 2017 | 3562 | 0.040 |
Why?
|
Ethanol | 1 | 2006 | 1323 | 0.040 |
Why?
|
Periodicity | 1 | 2001 | 348 | 0.040 |
Why?
|
Edema | 2 | 2014 | 770 | 0.040 |
Why?
|
Peripheral Arterial Disease | 1 | 2011 | 1305 | 0.040 |
Why?
|
Models, Structural | 1 | 2000 | 341 | 0.040 |
Why?
|
Oximetry | 1 | 2003 | 461 | 0.040 |
Why?
|
Rats, Inbred Strains | 2 | 1991 | 2094 | 0.040 |
Why?
|
C-Reactive Protein | 3 | 2011 | 3839 | 0.040 |
Why?
|
Infarction | 1 | 2020 | 248 | 0.040 |
Why?
|
Mice | 9 | 2005 | 81209 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2006 | 2698 | 0.040 |
Why?
|
Leptin | 2 | 2004 | 1590 | 0.040 |
Why?
|
Antihypertensive Agents | 1 | 2009 | 2061 | 0.040 |
Why?
|
Arteries | 3 | 2006 | 1126 | 0.040 |
Why?
|
Oscillometry | 1 | 1999 | 145 | 0.040 |
Why?
|
Rabbits | 2 | 2004 | 4773 | 0.040 |
Why?
|
Insurance Claim Reporting | 1 | 1999 | 165 | 0.040 |
Why?
|
Clinical Protocols | 1 | 2004 | 1440 | 0.040 |
Why?
|
Survival Analysis | 2 | 2009 | 10185 | 0.040 |
Why?
|
Troponin | 1 | 2022 | 516 | 0.040 |
Why?
|
Independent Living | 1 | 2022 | 570 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2012 | 2290 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6465 | 0.040 |
Why?
|
Medicare Part B | 1 | 1999 | 117 | 0.040 |
Why?
|
Tissue Survival | 1 | 2018 | 119 | 0.040 |
Why?
|
Cholesterol | 2 | 2011 | 2924 | 0.040 |
Why?
|
Colon | 1 | 2006 | 1788 | 0.040 |
Why?
|
Chest Pain | 1 | 2005 | 1106 | 0.040 |
Why?
|
Carotid Stenosis | 1 | 2005 | 872 | 0.040 |
Why?
|
False Negative Reactions | 2 | 2012 | 573 | 0.040 |
Why?
|
Feedback | 1 | 2021 | 791 | 0.040 |
Why?
|
Odds Ratio | 3 | 2016 | 9716 | 0.040 |
Why?
|
Glucose Tolerance Test | 2 | 2011 | 1174 | 0.040 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.040 |
Why?
|
Logistic Models | 4 | 2016 | 13312 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2012 | 10826 | 0.040 |
Why?
|
Referral and Consultation | 2 | 2002 | 3598 | 0.040 |
Why?
|
Patient Selection | 3 | 2016 | 4279 | 0.030 |
Why?
|
Heart-Assist Devices | 1 | 2007 | 1291 | 0.030 |
Why?
|
Patient Positioning | 1 | 2019 | 327 | 0.030 |
Why?
|
Anisotropy | 1 | 2000 | 1278 | 0.030 |
Why?
|
Computer Graphics | 1 | 1998 | 341 | 0.030 |
Why?
|
Quebec | 1 | 2016 | 142 | 0.030 |
Why?
|
Atrial Function | 1 | 1996 | 99 | 0.030 |
Why?
|
Radio Waves | 1 | 1997 | 250 | 0.030 |
Why?
|
Insulin Resistance | 1 | 2010 | 3959 | 0.030 |
Why?
|
Mutation | 3 | 2017 | 29957 | 0.030 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 1997 | 881 | 0.030 |
Why?
|
Collagen | 1 | 2024 | 2636 | 0.030 |
Why?
|
Sirolimus | 1 | 2003 | 1547 | 0.030 |
Why?
|
Anti-Arrhythmia Agents | 1 | 1999 | 784 | 0.030 |
Why?
|
Endothelium, Vascular | 2 | 2013 | 4434 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2008 | 5132 | 0.030 |
Why?
|
Time | 1 | 2017 | 545 | 0.030 |
Why?
|
Risk | 2 | 2013 | 9632 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2000 | 1722 | 0.030 |
Why?
|
Intraoperative Period | 1 | 1995 | 516 | 0.030 |
Why?
|
Prosthesis Design | 2 | 2013 | 2129 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 15790 | 0.030 |
Why?
|
Curriculum | 1 | 2008 | 3718 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2019 | 1180 | 0.030 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2014 | 119 | 0.030 |
Why?
|
Cell Survival | 1 | 2004 | 5797 | 0.030 |
Why?
|
Diabetes Mellitus | 2 | 2010 | 5890 | 0.030 |
Why?
|
Computer Simulation | 3 | 2010 | 6218 | 0.030 |
Why?
|
Tomography, Spiral Computed | 2 | 2006 | 273 | 0.030 |
Why?
|
Cost-Benefit Analysis | 3 | 2004 | 5508 | 0.030 |
Why?
|
Cognition | 1 | 2011 | 6964 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2016 | 494 | 0.030 |
Why?
|
Probability | 1 | 1999 | 2475 | 0.030 |
Why?
|
Creatinine | 2 | 2011 | 1904 | 0.030 |
Why?
|
Medical History Taking | 1 | 1997 | 773 | 0.030 |
Why?
|
Access to Information | 1 | 2016 | 320 | 0.030 |
Why?
|
Polysomnography | 1 | 2020 | 1825 | 0.030 |
Why?
|
Anesthesia, Conduction | 1 | 1996 | 261 | 0.030 |
Why?
|
Inflammation | 2 | 2011 | 10755 | 0.030 |
Why?
|
Rupture, Spontaneous | 1 | 2013 | 356 | 0.030 |
Why?
|
Infection Control | 1 | 2020 | 983 | 0.030 |
Why?
|
Obesity, Morbid | 1 | 2003 | 1287 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 1999 | 1723 | 0.030 |
Why?
|
Transcription Factors | 2 | 2003 | 12102 | 0.030 |
Why?
|
Rats | 5 | 2003 | 23709 | 0.030 |
Why?
|
Atrophy | 1 | 2017 | 1626 | 0.030 |
Why?
|
Device Removal | 1 | 2017 | 635 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 1997 | 899 | 0.020 |
Why?
|
Minnesota | 1 | 2012 | 340 | 0.020 |
Why?
|
beta-Alanine | 1 | 2012 | 82 | 0.020 |
Why?
|
Population Surveillance | 1 | 2002 | 2608 | 0.020 |
Why?
|
Cross-Over Studies | 2 | 2009 | 2061 | 0.020 |
Why?
|
Genotype | 3 | 2014 | 12957 | 0.020 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2000 | 1660 | 0.020 |
Why?
|
Canada | 1 | 2017 | 2126 | 0.020 |
Why?
|
Physical Examination | 1 | 1997 | 1244 | 0.020 |
Why?
|
Italy | 1 | 2013 | 841 | 0.020 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2012 | 125 | 0.020 |
Why?
|
Glucose Transporter Type 4 | 1 | 2011 | 240 | 0.020 |
Why?
|
Ankle Brachial Index | 1 | 2011 | 163 | 0.020 |
Why?
|
Angiostatins | 1 | 2010 | 64 | 0.020 |
Why?
|
Normal Distribution | 1 | 2011 | 273 | 0.020 |
Why?
|
Least-Squares Analysis | 1 | 2011 | 369 | 0.020 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2015 | 708 | 0.020 |
Why?
|
Software | 2 | 2002 | 4419 | 0.020 |
Why?
|
Mice, Inbred BALB C | 2 | 2003 | 6216 | 0.020 |
Why?
|
Faculty, Medical | 1 | 2018 | 1192 | 0.020 |
Why?
|
Blotting, Western | 2 | 2012 | 5039 | 0.020 |
Why?
|
Muscle Cells | 1 | 2011 | 195 | 0.020 |
Why?
|
Administration, Sublingual | 1 | 2010 | 58 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2013 | 585 | 0.020 |
Why?
|
Drug Therapy, Combination | 2 | 2012 | 6498 | 0.020 |
Why?
|
Forecasting | 1 | 1999 | 2931 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2013 | 987 | 0.020 |
Why?
|
Cholesterol, Dietary | 1 | 2010 | 223 | 0.020 |
Why?
|
Mice, Transgenic | 4 | 2003 | 9530 | 0.020 |
Why?
|
Sleep | 1 | 2005 | 4750 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2011 | 393 | 0.020 |
Why?
|
Vasculitis | 1 | 2013 | 523 | 0.020 |
Why?
|
Heart Function Tests | 1 | 2010 | 319 | 0.020 |
Why?
|
Anesthesia, General | 1 | 1996 | 1166 | 0.020 |
Why?
|
Collateral Circulation | 1 | 2010 | 292 | 0.020 |
Why?
|
Hypercalcemia | 1 | 2012 | 421 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 3113 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 1990 | 825 | 0.020 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2011 | 578 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2016 | 1405 | 0.020 |
Why?
|
Blood Volume | 1 | 1990 | 550 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2010 | 187 | 0.020 |
Why?
|
Endocardium | 1 | 2009 | 246 | 0.020 |
Why?
|
Heart Defects, Congenital | 2 | 2004 | 4673 | 0.020 |
Why?
|
Emergencies | 1 | 1995 | 1210 | 0.020 |
Why?
|
Information Dissemination | 1 | 2016 | 1131 | 0.020 |
Why?
|
Child, Preschool | 3 | 2006 | 42056 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2471 | 0.020 |
Why?
|
Sample Size | 1 | 2011 | 840 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2013 | 1206 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 1996 | 4815 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2716 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2009 | 465 | 0.020 |
Why?
|
Ventricular Premature Complexes | 1 | 2008 | 113 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2010 | 1098 | 0.020 |
Why?
|
Microvessels | 1 | 2011 | 572 | 0.020 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2008 | 152 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2012 | 858 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2003 | 5640 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3386 | 0.020 |
Why?
|
Drug Combinations | 1 | 1992 | 2025 | 0.020 |
Why?
|
Ticlopidine | 1 | 2012 | 895 | 0.020 |
Why?
|
Pedigree | 1 | 2014 | 4578 | 0.020 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2008 | 252 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2016 | 2001 | 0.020 |
Why?
|
Insulin | 2 | 2011 | 6596 | 0.020 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2009 | 479 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2235 | 0.020 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2010 | 866 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4108 | 0.020 |
Why?
|
Cadherins | 1 | 2010 | 898 | 0.020 |
Why?
|
Protein Transport | 1 | 2011 | 1964 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2012 | 1797 | 0.020 |
Why?
|
Models, Biological | 1 | 2001 | 9468 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 1997 | 8552 | 0.020 |
Why?
|
Credentialing | 1 | 2005 | 115 | 0.020 |
Why?
|
Blood Glucose | 2 | 2010 | 6379 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2011 | 2222 | 0.020 |
Why?
|
Injections, Intra-Arterial | 1 | 2004 | 182 | 0.010 |
Why?
|
Tissue Distribution | 2 | 2002 | 2262 | 0.010 |
Why?
|
Preoperative Care | 1 | 2013 | 2255 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 1997 | 3200 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2005 | 613 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2017 | 17790 | 0.010 |
Why?
|
Myosin Light Chains | 1 | 2003 | 121 | 0.010 |
Why?
|
Ribosomal Protein S6 | 1 | 2003 | 71 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2003 | 74 | 0.010 |
Why?
|
Constriction | 1 | 2003 | 171 | 0.010 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2003 | 101 | 0.010 |
Why?
|
Microcirculation | 1 | 2008 | 1278 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2010 | 1341 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2004 | 1142 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2008 | 1259 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6831 | 0.010 |
Why?
|
Drug-Eluting Stents | 1 | 2009 | 757 | 0.010 |
Why?
|
Dilatation, Pathologic | 1 | 2003 | 527 | 0.010 |
Why?
|
Ghrelin | 1 | 2004 | 252 | 0.010 |
Why?
|
Quality Control | 1 | 2004 | 828 | 0.010 |
Why?
|
Lung | 1 | 2000 | 9994 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2004 | 956 | 0.010 |
Why?
|
Sodium-Calcium Exchanger | 1 | 2001 | 89 | 0.010 |
Why?
|
Placebos | 1 | 2005 | 1668 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2012 | 3106 | 0.010 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2003 | 410 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2696 | 0.010 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2001 | 128 | 0.010 |
Why?
|
Age of Onset | 1 | 2008 | 3302 | 0.010 |
Why?
|
Educational Measurement | 1 | 2008 | 1248 | 0.010 |
Why?
|
Heart Septum | 1 | 2002 | 303 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 2004 | 1754 | 0.010 |
Why?
|
Thinness | 1 | 2004 | 491 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 2049 | 0.010 |
Why?
|
Infant | 1 | 2022 | 36053 | 0.010 |
Why?
|
Foreign-Body Migration | 1 | 2002 | 218 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2009 | 2634 | 0.010 |
Why?
|
Education, Medical, Continuing | 1 | 2005 | 830 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2003 | 2558 | 0.010 |
Why?
|
Hemorrhage | 1 | 2012 | 3599 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4000 | 0.010 |
Why?
|
Species Specificity | 1 | 2004 | 2418 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2011 | 11902 | 0.010 |
Why?
|
Connexins | 1 | 2001 | 351 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 1999 | 6853 | 0.010 |
Why?
|
Japan | 1 | 2003 | 1369 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2005 | 14374 | 0.010 |
Why?
|
Barium Sulfate | 1 | 1999 | 180 | 0.010 |
Why?
|
Sigmoidoscopy | 1 | 1999 | 150 | 0.010 |
Why?
|
Enema | 1 | 1999 | 141 | 0.010 |
Why?
|
Adenoviridae | 1 | 2003 | 1084 | 0.010 |
Why?
|
Injections | 1 | 2002 | 830 | 0.010 |
Why?
|
Michigan | 1 | 1999 | 342 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2011 | 7022 | 0.010 |
Why?
|
Heterozygote | 1 | 2005 | 2798 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2011 | 3392 | 0.010 |
Why?
|
Teaching | 1 | 2006 | 1169 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2003 | 1246 | 0.010 |
Why?
|
Plasmids | 1 | 2003 | 2275 | 0.010 |
Why?
|
Smoking | 1 | 2014 | 9073 | 0.010 |
Why?
|
Rest | 1 | 2002 | 914 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 2001 | 1067 | 0.010 |
Why?
|
Postmenopause | 1 | 2005 | 2509 | 0.010 |
Why?
|
Models, Statistical | 1 | 2011 | 5075 | 0.010 |
Why?
|
Models, Cardiovascular | 1 | 2002 | 977 | 0.010 |
Why?
|
Posture | 1 | 2000 | 953 | 0.010 |
Why?
|
Protein Kinases | 1 | 2003 | 1612 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2001 | 2671 | 0.010 |
Why?
|
Fetus | 1 | 2003 | 1859 | 0.010 |
Why?
|
Genetic Testing | 1 | 2008 | 3531 | 0.010 |
Why?
|
Vascular Diseases | 1 | 2004 | 1181 | 0.010 |
Why?
|
Rana catesbeiana | 1 | 1994 | 85 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2014 | 12628 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2005 | 2554 | 0.010 |
Why?
|
Down-Regulation | 1 | 2001 | 2913 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2003 | 2058 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2003 | 3380 | 0.010 |
Why?
|
Diet | 1 | 2011 | 8010 | 0.010 |
Why?
|
Models, Chemical | 1 | 1994 | 614 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2003 | 5782 | 0.010 |
Why?
|
Phosphorylation | 1 | 2003 | 8311 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2003 | 3448 | 0.010 |
Why?
|
Gene Expression | 1 | 2003 | 7587 | 0.010 |
Why?
|
Body Weight | 1 | 2001 | 4611 | 0.010 |
Why?
|
Regression Analysis | 1 | 1998 | 6359 | 0.010 |
Why?
|
Cattle | 1 | 1994 | 3847 | 0.000 |
Why?
|
Calcium | 1 | 2001 | 5725 | 0.000 |
Why?
|
RNA, Messenger | 1 | 2003 | 12762 | 0.000 |
Why?
|
Cartilage, Articular | 1 | 1994 | 1091 | 0.000 |
Why?
|
Socioeconomic Factors | 1 | 1999 | 7805 | 0.000 |
Why?
|
Brain Ischemia | 1 | 1998 | 3127 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1994 | 8158 | 0.000 |
Why?
|
Signal Transduction | 1 | 2005 | 23374 | 0.000 |
Why?
|
Health Services Accessibility | 1 | 1999 | 5397 | 0.000 |
Why?
|